| |
| |
|
| Insider
Information: |
Lewis Michael E |
| Relationship: |
Chief Scientific Advisor |
| City: |
Rtp |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
814,988 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$237,973 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
814,988 |
|
|
| Total
Value |
$237,973 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Polymedix Inc |
PYMXQ |
Director |
2006-07-19 |
500,000 |
|
0 |
Premium* |
|
|
Cara Therapeutics, Inc. |
CARA |
Chief Scientific Advisor |
2016-01-26 |
314,988 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2016-01-26 |
4 |
AS |
$10.93 |
$79,374 |
D/D |
(7,262) |
314,988 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2015-07-01 |
4 |
AS |
$11.66 |
$84,675 |
D/D |
(7,262) |
322,250 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2015-06-01 |
4 |
AS |
$9.50 |
$68,989 |
D/D |
(7,262) |
329,512 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2015-05-01 |
4 |
AS |
$10.64 |
$77,268 |
D/D |
(7,262) |
336,774 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2015-04-01 |
4 |
AS |
$9.90 |
$71,894 |
D/D |
(7,262) |
344,036 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2015-03-02 |
4 |
AS |
$10.11 |
$73,419 |
D/D |
(7,262) |
351,298 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2015-02-02 |
4 |
AS |
$10.60 |
$76,977 |
D/D |
(7,262) |
358,560 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Advisor |
• – – |
2014-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
43,572 |
365,822 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific AdvisorOffice |
• – – |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
322,250 |
|
- |
|
| PYMXQ |
Polymedix Inc |
Director |
– • – |
2006-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500,000 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
